Business Description
Surgical Science Sweden AB
ISIN : SE0014428512
Compare
Compare
Traded in other countries / regions
SUS.SwedenSUSRF.USA4P41.Germany IPO Date
2019-11-04Description
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments; Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations, prior to entering the clinical environment and also support and services, and Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments and also simulators for medical device companies.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 16.65 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.18 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 14.36 | |||||
| Beneish M-Score | -2.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 78.5 | |||||
| 3-Year EBITDA Growth Rate | 80.6 | |||||
| 3-Year EPS without NRI Growth Rate | 116.9 | |||||
| 3-Year FCF Growth Rate | 108.1 | |||||
| 3-Year Book Growth Rate | 90.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 20.18 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 14.65 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.26 | |||||
| 9-Day RSI | 75.91 | |||||
| 14-Day RSI | 77.76 | |||||
| 6-1 Month Momentum % | 2.41 | |||||
| 12-1 Month Momentum % | 7.69 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.44 | |||||
| Quick Ratio | 3.73 | |||||
| Cash Ratio | 2.73 | |||||
| Days Inventory | 229.22 | |||||
| Days Sales Outstanding | 48.78 | |||||
| Days Payable | 55.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.9 | |||||
| Shareholder Yield % | -0.32 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.65 | |||||
| Operating Margin % | 16.61 | |||||
| Net Margin % | 22.49 | |||||
| FCF Margin % | 8.48 | |||||
| ROE % | 4.3 | |||||
| ROA % | 3.97 | |||||
| ROIC % | 2.77 | |||||
| 3-Year ROIIC % | 4.12 | |||||
| ROC (Joel Greenblatt) % | 221.28 | |||||
| ROCE % | 4.83 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 41.5 | |||||
| Forward PE Ratio | 31.94 | |||||
| PE Ratio without NRI | 41.5 | |||||
| Price-to-Owner-Earnings | 90.45 | |||||
| PEG Ratio | 0.48 | |||||
| PS Ratio | 9.34 | |||||
| PB Ratio | 1.8 | |||||
| Price-to-Tangible-Book | 9.8 | |||||
| Price-to-Free-Cash-Flow | 110 | |||||
| Price-to-Operating-Cash-Flow | 66.79 | |||||
| EV-to-EBIT | 33.39 | |||||
| EV-to-Forward-EBIT | 21.67 | |||||
| EV-to-EBITDA | 33.39 | |||||
| EV-to-Forward-EBITDA | 18.37 | |||||
| EV-to-Revenue | 8.64 | |||||
| EV-to-Forward-Revenue | 6.48 | |||||
| EV-to-FCF | 101.82 | |||||
| Price-to-Projected-FCF | 1.78 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.66 | |||||
| Price-to-Graham-Number | 4.25 | |||||
| Price-to-Net-Current-Asset-Value | 10.98 | |||||
| Price-to-Net-Cash | 25.44 | |||||
| Earnings Yield (Greenblatt) % | 2.99 | |||||
| FCF Yield % | 0.91 | |||||
| Forward Rate of Return (Yacktman) % | 21.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SUSRF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Surgical Science Sweden AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 83.163 | ||
| EPS (TTM) ($) | 0.367 | ||
| Beta | 0.42 | ||
| Volatility % | 31.77 | ||
| 14-Day RSI | 77.76 | ||
| 14-Day ATR ($) | 0.121095 | ||
| 20-Day SMA ($) | 13.6635 | ||
| 12-1 Month Momentum % | 7.69 | ||
| 52-Week Range ($) | 11.3 - 14.53 | ||
| Shares Outstanding (Mil) | 51.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Surgical Science Sweden AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Surgical Science Sweden AB Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Surgical Science Sweden AB Frequently Asked Questions
What is Surgical Science Sweden AB(SUSRF)'s stock price today?
The current price of SUSRF is $14.50. The 52 week high of SUSRF is $14.53 and 52 week low is $11.30.
When is next earnings date of Surgical Science Sweden AB(SUSRF)?
The next earnings date of Surgical Science Sweden AB(SUSRF) is 2025-02-19.
Does Surgical Science Sweden AB(SUSRF) pay dividends? If so, how much?
Surgical Science Sweden AB(SUSRF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers